Back to Search
Start Over
Secondary prevention of venous thromboembolic complications. Focus on dabigatrane
- Source :
- Амбулаторная хирургия, Vol 0, Iss 3-4, Pp 36-42 (2017)
- Publication Year :
- 2017
- Publisher :
- Remedium Group LTD, 2017.
-
Abstract
- Venous thromboembolic complications (VTEC) are a frequent pathology accompanied by high lethality. After VTEC the risk of their recurrence not equivalent for all patients remains. The anticoagulant therapy available currently effectively prevents VTEC increasing a possibility of hemorrhages. This means that at planning the secondary prevention it’s necessary to maintain the optimal balance between a possibility of recurrence of VTEC and development of hemorrhagic complications. Thus, selection of patients for secondary prevention must be accompanied by a comprehensive analysis of numerous factors as determining the possibility of VTEC recurrence as well as a risk of complications development. Warfarin is the most frequently used drug for long-term anticoagulant per os therapy, it requires frequent monitoring with periodic dose correction and strict dietary limitations. New oral anticoagulants (NOAC) are applied at a fixed dose without obligatory strict hemostasiologic control, which makes them rather attractive for continues secondary prevention of VTEC.
Details
- Language :
- Russian
- ISSN :
- 27128741 and 27822591
- Issue :
- 3-4
- Database :
- Directory of Open Access Journals
- Journal :
- Амбулаторная хирургия
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2bf3efd786f402abb882f4b2e99b423
- Document Type :
- article